Delivered-To: rait@bruce-guenter.dyndns.org
Received: (qmail 1430 invoked from network); 26 Apr 2010 17:33:25 -0000
Received: from localhost (localhost [127.0.0.1])
  by bruce-guenter.dyndns.org ([192.168.1.2]); 26 Apr 2010 17:33:25 -0000
Received: from zak.futurequest.net ([127.0.0.1])
  by localhost ([127.0.0.1])
  with SMTP via TCP; 26 Apr 2010 17:33:25 -0000
Received: (qmail 23115 invoked from network); 26 Apr 2010 17:33:24 -0000
Received: from arcelik-f9f183e (unknown [188.58.139.36])
  by zak.futurequest.net ([69.5.6.152])
  with ESMTP via TCP; 26 Apr 2010 17:33:18 -0000
Received: from 188.58.139.36 by gw-mail6.ctsinternet.net; Mon, 26 Apr 2010 19:33:20 +0200
From: "MaxGentleman" <xhxyp@bondnbotes.com>
To: <pbuuac@bruce-guenter.dyndns.org>
Subject: All gains in length and width are 100% permanent in clinical trials.
Date: Mon, 26 Apr 2010 19:33:20 +0200
MIME-Version: 1.0
Content-Type: text/plain;
	charset="iso-8859-1"
Content-Transfer-Encoding: 7bit
X-Mailer: Microsoft Office Outlook, Build 11.0.5510
Thread-Index: Aca6QF7M2YSUGPCMS5YATKH9X5S1OB==
X-MimeOLE: Produced By Microsoft MimeOLE V6.00.2800.1106
Message-ID: <01cae577$53c181e0$248b3abc@xhxyp>

http://su.pr/2ZPpDZ

